TOXINS 2021: New analyses of pivotal Phase III trial data highlight long duration of response for Dysport® (abobotulinumtoxinA) in five therapeutic indications -Today at 12:08 pm

Analyses of pivotal study data of Dysport® reveal a large proportion of study patients did not require retreatment for at least 12 weeks


This new analysis...

Related Keywords

United Kingdom ,Minnesota ,United States ,Paris ,France General ,France ,American ,British ,Frederic Bard ,Renaud Morin ,Jorge Jacinto ,Natalya Danchenko ,Magali Volteau ,Hamzah Baig ,John Whalen ,Stephen Mcmahon ,Jean Michel Lagarde ,Stefan Wietek ,Amy Fisher ,Alison Mason ,David Gruber ,Johannes Krupp ,Ipsen Euronext ,Kevin Moore ,Jean Michel Gracies ,Marcin Bonikowski ,Benjamin Ascher ,Pascal Maisonobe ,Andreas Lysandropoulos ,Davidg Armstrong ,Felicia Tay ,Steven Hildemann ,Karissa Johnston ,Ann Tilton ,Edward Dabrowski ,Cillian Paget ,Cynthia Comella ,Alina Bugajewska Waller ,Klemens Fheodoroff ,Nigar Dursun ,Kailash Bhatia ,Mikhail Kalinichev ,Keith Foster ,Seleneg Parekh ,Sarah Helen Evans ,Matthew Beard ,Iwona Ziomkiewicz ,Roongroj Bhidayasiri ,Stephane Lezmi ,Philippe Kestemont ,Richardm Trosch ,Benjamin Regnault ,Jorge Carranza ,Catherine Thompson ,Mauricior Delgado ,Joyce Oleszek ,Mark Gormley ,Elena Gubanova ,Lorraine Cuffe ,Lawrencea Didomenico ,Beatriz Molina ,Alberto Esquenazi ,Daniel Higazi ,Allison Brashear ,Robert Silva ,Jeremy Lambert ,Riekie Smit ,Cindy Perier ,Alessio Redaelli ,Beatrice Oehler ,Marina Landau ,Stephen Ashford ,Williams Olughu ,Talshyn Bolatova ,Michael Williams ,Jeremy Yeo ,Julie Tiley ,Antony Fulford Smith ,Denis Carr ,Joely Kaufman ,Lynne Turner ,Carlo Colosimo ,Babak Baravarian ,Raymondl Rosales ,Mo Chung ,David Allcock ,Roberta Hauser ,Andrew Splevins ,Joaquimj Ferreira ,Stanislav Pepeliaev ,Asare Christian ,Virtual Congress ,International Neurotoxin Association ,Motion Analysis Laboratory ,Royal College Of Physicians ,National Institute Of Neurological Disorders ,National Guidelines ,Movement Disorders ,Virtual Congress Hall ,American Association Of Neurological Surgeons ,British Society Of Rehabilitation ,Head Of Global Medical Affairs ,Digitisation Of Toxin Development ,Long Duration ,Sheerr Gait ,Executive Vice President ,Chief Medical Officer ,Global Medical Affairs ,Patient Safety ,Systematic Approach ,Cell Free Platform Process ,Recombinant Toxin ,Sian Richardson ,Prabotulinumtoxin Type ,Marine Norlund ,Functional Genomics Reveals ,Unexpected Trafficking ,Omar Loss ,Symptom Re Emergence ,Patients Living ,Cervical Dystonia ,Patient Surveys ,Treatment Satisfaction Over ,Botulinum Neurotoxin ,Treatment Cycle ,Goal Attainment ,Primary Results ,Life Data ,Botulinum Toxin ,Upper Limb Spasticity ,Lynne Turner Stokes ,Outcomes Following Treatment ,Controlled Clinical ,Carlos Dur ,Spastic Paresis ,Cervical Dystonia Management ,Seven Years ,Tae Mo Chung ,Term Efficacy ,Liquid Formulation Abobotulinumtoxina ,Moderate To Severe Glabellar Lines ,Open Label Repeat Injection ,Said Hilton ,Bill Andriopoulos ,Inna Prygova ,Adult Spasticity ,Cost Effectiveness Analysis ,Pediatric Spasticity ,Spasticity Related Quality ,Dimensions Tool ,First Psychometric ,Christine De La Loge ,Hallux Valgus ,Adult Patients ,Placebo Controlled Phase ,Pivotal Study ,Abobotulinumtoxina Injection ,Upper Limb Muscles ,Pediatric Patients ,Pediatric Lower Limb Spasticity ,Interim Results ,Hygiene Extension Limb Position Pain ,Monitor Waning ,Clinical Efficacy ,Cervical Dystonia Treated ,Accessed December ,British Society ,Neurological Disorders ,Dystonias Fact ,Systematic Reviews ,Markets ,